Document is current
Any future updates will be listed below
-
Authors
Perry, Lucy T. https://orcid.org/0000-0002-3337-1321
Mohammad, Annim https://orcid.org/0000-0003-3744-2219
Hooimeyer, Ashleigh https://orcid.org/0000-0002-8526-1837
McEwin, Eliza J. https://orcid.org/0000-0003-2225-3474
Mintzes, Barbara https://orcid.org/0000-0002-8671-915X
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (APP 1122332)
Canadian Institutes of Health Research (PJT-153275)
University of Sydney
- License Information
-
More Information
Article History
Accepted: 14 July 2025
First Online: 4 August 2025
Declarations
:
: Open Access funding enabled and organized by CAUL and its Member Institutions. This work was supported by grants from the Australian National Health and Medical Research Council (APP 1122332) and Canadian Institutes of Health Research (PJT-153275).
: BM has acted as an expert witness for Health Canada and is currently an expert witness for the Australian Therapeutic Goods Administration on two legal challenges of regulatory decisions; she has no other competing interests. LTP, EJM, AH and AM have no competing interests.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: Not required.
: Not applicable.
: Not applicable.
: Not applicable.
: Conceptualization: Lucy T Perry. Methodology: Lucy T Perry and Barbara Mintzes. Data curation: Lucy T Perry, Annim Mohammad, Ashleigh Hooimeyer, and Eliza J McEwin. Formal analysis and investigation: Lucy T Perry. Writing – original draft preparation: Lucy T Perry. Writing – review and editing: Lucy T Perry, Annim Mohammad, Ashleigh Hooimeyer, Eliza J McEwin, and Barbara Mintzes. Funding acquisition: Barbara Mintzes. Supervision: Barbara Mintzes. All authors read and approved the final version.
